Search

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination - Nature.com

berukcepat.blogspot.com

Abstract

SARS-CoV-2 Delta and Omicron are globally relevant variants of concern (VOCs). While individuals infected with Delta are at risk to develop severe lung disease, infection with Omicron often causes milder symptoms, especially in vaccinated individuals1,2. The question arises whether widespread Omicron infections could lead to future cross-variant protection, accelerating the end of the pandemic. Here we show that without vaccination, infection with Omicron induces a limited humoral immune response in mice and humans. Sera from mice overexpressing the human ACE2 receptor and infected with Omicron neutralize only Omicron, but no other VOCs, whereas broader cross-variant neutralization was observed after WA1 and Delta infections. Unlike WA1 and Delta, Omicron replicates to low levels in the lungs and brains of infected animals, leading to mild disease with reduced pro-inflammatory cytokine expression and diminished activation of lung-resident T cells. Sera from unvaccinated, Omicron-infected individuals show the same limited neutralization of only Omicron itself. In contrast, Omicron breakthrough infections induce overall higher neutralization titers against all VOCs. Our results demonstrate that Omicron infection enhances preexisting immunity elicited by vaccines but, on its own, may not confer broad protection against non-Omicron variants in unvaccinated individuals.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Nadia R. Roan, Charles Y. Chiu, Jennifer A. Doudna or Melanie Ott.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Suryawanshi, R.K., Chen, I.P., Ma, T. et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature (2022). https://ift.tt/7KmwnvL

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://ift.tt/7KmwnvL

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Adblock test (Why?)



"cros" - Google News
May 18, 2022 at 04:19PM
https://ift.tt/UFJ6kBd

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination - Nature.com
"cros" - Google News
https://ift.tt/096O2W7
https://ift.tt/akpxM4F

Bagikan Berita Ini

0 Response to "Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination - Nature.com"

Post a Comment

Powered by Blogger.